Jane Street
OMIC

Jane Street’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Jane Street’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-433
Closed -$4.94K – 9976
2023
Q3 		$4.94K Sell
433
-1,245
-74% -$23.1K ﹤0.01% 8442
2023
Q2 		$41.8K Buy
+1,678
New +$49.2K ﹤0.01% 8248
2023
Q1 		– Sell
-1,354
Closed -$81.6K – 10194
2022
Q4 		$81.6K Buy
+1,354
New +$90.7K ﹤0.01% 8204
2022
Q1 		– Sell
-538
Closed -$187K – 11221
2021
Q4 		$187K Buy
+538
New +$209K ﹤0.01% 8865

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's OMIC Position: Q4 2023 in Review

Jane Street sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2023, closing a stake of 433 shares — an estimated $4.94K sold.

Jane Street first reported a position in OMIC in Q4 2021 and held it in 4 quarters. The position peaked at $187K in Q4 2021. 47 funds tracked by Wall St. Rank hold OMIC as of Q4 2023.

  • Jane Street reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jane Street sold 433 Singular Genomics Systems, Inc. Common Stock shares in Q4 2023, an estimated $4.94K.
  • Jane Street first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Jane Street's Singular Genomics Systems, Inc. Common Stock position peaked at $187K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.